a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4.

J Med Chem. 2018 Jan 30. doi: 10.1021/acs.jmedchem.7b01914. [Epub ahead of print]
3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4.
Ren Q1,2, Liu X1,2, Yan G1,2, Nie B1, Zou Z1,2, Li J1, Chen Y1, Wei Y1, Huang J1,2, Luo Z1, Gu B1, Goldmann S1,2, Zhang J3, Zhang Y1.

renlingaaaa